| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -7,500 | -4,238 |
| Depreciation | 11 | 7 |
| Share-based payment arrangement, noncash expense | 96 | 58 |
| Other noncash income (expense) | -294 | - |
| Other noncash expense | - | 310 |
| Loss from lease termination | 0 | - |
| Increase in prepaid expenses | 773 | 717 |
| Decrease (increase) in other current assets | -15 | 1 |
| Increase (decrease) in accounts payable, trade | 17 | -237 |
| Increase (decrease) in operating lease liability | -1 | 1 |
| Increase (decrease) in employee related liabilities | 79 | -14 |
| Increase (decrease) in other accounts payable and accrued liabilities | -41 | -129 |
| Net cash provided by (used in) operating activities | -7,803 | -4,960 |
| Purchase of property and equipment | 7 | 7 |
| Net cash provided by (used in) investing activities | -7 | -7 |
| Proceeds from issuance of common stock | 0 | - |
| Cash acquired in excess of payments to acquire business | 0 | - |
| Proceeds from stock options exercised | - | 0 |
| Represents proceeds from issuance of ordinary shares upon public offering | 11,000 | 5,000 |
| Proceeds from issuance initial public offering | -1,398 | -745 |
| Proceeds from warrant exercises | 2,644 | 864 |
| Represents proceeds from issuance of ordinary shares upon warrants inducement | 5,036 | 3,276 |
| Issuance costs related to warrants inducement transactions | 694 | 462 |
| Represent the value of payment of underwriters promissory note | -696 | -696 |
| Represents the amount of prepaid of issuance cost related to at the market offering | 31 | - |
| Net cash provided by (used in) financing activities | 15,861 | 7,237 |
| Cash, cash equivalents, restricted cash, and restricted cash equivalents, period increase (decrease), excluding exchange rate effect | 8,051 | 2,270 |
| Effect of exchange rate changes on cash | 3 | - |
| Cash and cash equivalents at beginning of period | 1,270 | - |
| Cash and cash equivalents at end of period | 9,324 | - |
Silexion Therapeutics Corp (SLXN)
Silexion Therapeutics Corp (SLXN)